Treatment of Recurrent <scp>IgA</scp> Nephropathy After Kidney Transplantation: Case Report and Comprehensive Literature Review
Recurrent IgA nephropathy after kidney transplantation remains a major cause of graft dysfunction. This case highlights successful management with targeted-release budesonide combined with sparsentan, underscoring the importance of early recognition and the promise of emerging therapies to preserve long-term allograft function.
Authors
- Nasrollah Ghahramani (ORCID: https://orcid.org/0000-0002-0299-9394)
- Megha Koirala (ORCID: https://orcid.org/0000-0003-2944-9883)
- Amanda Karasinski
- Vaqar H. Shah
- Ahmad Matarneh (ORCID: https://orcid.org/0000-0002-7091-310X)
- Omar Salameh (ORCID: https://orcid.org/0000-0002-9190-0439)
- Gurwant Kaur (ORCID: https://orcid.org/0000-0002-8890-3962)
- Naman Trivedi
Institutions
- Truman Medical Center (US)
- Universidad Nacional del Litoral (AR)
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/ccr3.71474
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Pennsylvania
- Pennsylvania State University